The E-Cigarette Summit 2021
The UK E-Cigarette Summit which will take place virtually on 7-8 December 2021 and hope that the Virtual Summit will provide a welcoming focal point to grapple with the challenging…
Plos Biology: 9 more excellences from the CoEHAR of the University of Catania
These are the professors: Margherita Ferrante, Antonio Gagliano, Fabio Galvano, Giuseppe Grasso, Sandro La Vignera, Venerando Rapisarda.
Prof. Caruso, from CoEHAR, joined CORESTA SSPT2021 Conference
The main goal of the Conference is to introduce the current status of New Alternative Methods and their potential to support Tobacco Harm Reduction worldwide. The aim of the CORESTA conference is also to foster scientific engagement between CORESTA members and THR international community to facilitate the discussion around reduced risk devices and support evidence-based tobacco regulatory policies.
Harm Reduction and bias: a review confirms that ecigs are less harmful, but high-quality studies are much needed
"It is surprising to note that there are very few studies that can be considered truly informative of the risk-benefit ratio of new technologies with reduced risk in terms of their impact on health. We are proud to say that CoEHAR research ranks among the best in the current scientific landscape"
The CoEHAR smile operation has started: enrolled the first patient of Smile Study
With the enrollment of the first patient, the project has officially started, thanks to the collaboration of international renew partners: the Addendo Clinic (Catania), the University of Modena and Reggio Emilia, the University of Bologna, and research centres in Warsaw (Poland), Chisinau (Moldova) and Bandung (Indonesia).
DIASMOKE: the patient recruitment phase has officially started
CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, has launched a two-year study, the Diasmoke project, to investigate whether vaping or using E-cigarettes reduces the risk of cardiovascular (heart and circulation) disease as compared to normal smoking.
Ecigs and Heated Tobacco Products: an innovative new CoEHAR study assesses the harm reversal on respiratory cilia
For the first time, CoEHAR researchers used the saccharin test transit time to compare the data on the regeneration of respiratory cilia among current, former and never smokers, electronic cigarette users and heated tobacco products users. The results suggest that combustion-free nicotine delivery technologies are unlikely to have detrimental effects on mucociliary clearance
ECIG: a new study by CoEHAR screens different lab tests to evaluate the potential risk
The aim of the study is to investigate different in vitro toxicity methods for the assessment of ENDs toxicity. According to the Italian researchers, the most used assay, the neutral red uptake, should be combined with different tools (enlisted in the study) to better identifies the toxicity of the products and can avoid approximate and incorrect evaluation
Fewer exacerbations and higher quality of life in COPD: Interview with Prof. Polosa
Professor Riccardo Polosa discuss in an interview on Medical Tribune the results of his study: heated tobacco products produce fewer exacerbations and better quality of life in COPD patients compared to conventional cigarettes.
REPLICA announces its third Harmonization Meeting
The REPLICA Project is proud to announce the third Harmonization meeting involving researchers and international partners. The two-day session is going to be held on May 26 and May 28 2021
- Go to the previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- Go to the next page
